Trial intelligence / Profile preview

Eldecalcitol plus alendronate versus alendronate alone in primary osteoporosis

jRCT1080221612Phase 4

Sponsor
Chugai Pharmaceutical Co., Ltd.
Start
Oct 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of eldecalcitol in involutional osteoporosis (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd.

02

Drugs

eldecalcitol
03

Conditions

involutional osteoporosis

Beyond the preview

Go deeper on jRCT1080221612.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080221612.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call